期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

纳米载体包裹的蒽环类药物在儿童血液肿瘤疾病中的应用综述 被引量：2

Application of Nano-carrier loaded anthracyclines in pediatric patients with hematological malignancies
下载PDF
导出
摘要 被纳米载体包裹的蒽环类抗肿瘤药物在小儿血液系统肿瘤疾病化疗中有广泛应用前景,目前主要应用的是载体包裹的柔红霉素、阿霉素和米托蒽醌,本文回顾其作用特性及其在治疗中的作用。 Nano-carrier loaded anthracyclines based chemotherapies, such as daunorubicin, doxorubicin and mitoxantrone are widely used in the treatment of pediatric hematological malignancies. This review focuses on the characteristics of carrier loaded anthracyclines and their clinical application.
作者 翟谦宇 唐锁勤 ZHAI Qianyu TANG Suoqin(Department of Pediatrics, Chinese PLA General Hospital, Beijing 100853, China)
机构地区 解放军总医院小儿内科
出处 《解放军医学院学报》 CAS 2017年第7期706-708,共3页 Academic Journal of Chinese PLA Medical School
基金 国家863基金项目(2012AA020804)~~
关键词 蒽环类 儿童 纳米载体 血液肿瘤 anthracycline child nano carrier hematologic tumor
分类号 R733 [医药卫生—肿瘤] R725.5 [医药卫生—儿科]
  • 相关文献

参考文献4

二级参考文献74

  • 1Koeller J, Eble M. Mitoxantrone: a novel anthracycline derivative [J]. Clin Pharm, 1988, 7: 574-581.
  • 2Wiseman LR, Spencer CM. Mitoxantrone: a review of its pharmacology and clinical efficacy in the management of hormone-resistant advanced prostate cancer [J]. Drugs Aging 1997, 10: 473-485.
  • 3Dunn CJ, Goa KL. Mitoxantrone: a review of its pharmacological properties and use in acute nonlymphoblastic leukaemia [J]. Drugs Aging, 1996, 9: 122-147.
  • 4Kroger N, Damon L, Zander AR, et al. Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients [J]. Bone Marrow Transplant, 2003, 32:1153-1157.
  • 5Gabizon A, Shmeeda H, Barenholz Y. Pharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studies [J]. Clin Pharmacokinet, 2003, 42: 419-436.
  • 6Immordino ML, Dosio F, Cattel L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential [J]. Int J Nanomed, 2006, 1: 297-315.
  • 7Johnson JL, Ahmad A, Khan S, et al. Improved liquid chromatographic method for mitoxantrone quantification in mouse plasma and tissues to study the pharmacokinetics of a liposome entrapped mitoxantrone formulation [J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2004, 799: 149-155.
  • 8Lim HJ, Masin D, Madden TD, et al. Influence of drug release characteristics on the therapeutic activity of liposomal mitoxantrone [J]. J Pharmacol Exp Ther, 1997, 281: 566- 573.
  • 9Li CL, Cui JX, Wang CX, et al. Lipid composition and grafted PEG affect in vivo activity of liposomal mitoxantrone [J]. Int J Pharm, 2008, 362: 60-66.
  • 10Li CL, Cui JX, Wang CX, et al. Encapsulation of mitoxantrone into pegylated SUVs enhances its antineoplastic efficacy [J]. Eur J Pharm Biopharm, 2008, 70: 665-668.

共引文献18

同被引文献17

引证文献2

二级引证文献3

解放军医学院学报
2017年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部